NAV

Octacosanol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Octacosanol
DrugBank Accession Number
DB11220
Background

1-octacosanol is a straight-chain aliphatic 28-carbon primary fatty alcohol that is used as a nutritional supplement. This high–molecular-weight organic compound is the main component of a natural product wax extracted from plants 1. 1-octacosanol is reported to possess cholesterol-lowering effects, antiaggregatory properties, cytoprotective use, and ergogenic properties 1. It has been studied as a potential therapeutic agent for the treatment of Parkinson's disease.

Type
Small Molecule
Groups
Nutraceutical
Structure
Similar Structures
Weight
Average: 410.7595
Monoisotopic: 410.448766478
Chemical Formula
C28H58O
Synonyms
  • 1-Octacosanol
  • cluytyl alcohol
  • montanyl alcohol
  • n-octacosanol
  • Octacosanol
  • Octacosyl alcohol
External IDs
  • NSC-10770

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ginsamin PowerOctacosanol (3 mg/1) + Ginkgo biloba (80.4 mg/1) + Ginseng (118.2 mg/1) + Zinc (5.4 mg/1)TabletOralBiogrand Co., Ltd2010-03-07Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ginsamin PowerOctacosanol (3 mg/1) + Ginkgo biloba (80.4 mg/1) + Ginseng (118.2 mg/1) + Zinc (5.4 mg/1)TabletOralBiogrand Co., Ltd2010-03-07Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Fatty Acyls
Sub Class
Fatty alcohols
Direct Parent
Fatty alcohols
Alternative Parents
Primary alcohols / Hydrocarbon derivatives
Substituents
Alcohol / Aliphatic acyclic compound / Fatty alcohol / Hydrocarbon derivative / Organic oxygen compound / Organooxygen compound / Primary alcohol
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
long-chain primary fatty alcohol, fatty alcohol 28:0 (CHEBI:28243) / Fatty alcohols (LMFA05000003) / a long-chain alcohol, a primary alcohol, a fatty alcohol (CPD-7872)
Affected organisms
Not Available

Chemical Identifiers

UNII
81I2215OVK
CAS number
557-61-9
InChI Key
CNNRPFQICPFDPO-UHFFFAOYSA-N
InChI
InChI=1S/C28H58O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29/h29H,2-28H2,1H3
IUPAC Name
octacosan-1-ol
SMILES
CCCCCCCCCCCCCCCCCCCCCCCCCCCCO

References

General References
  1. Taylor JC, Rapport L, Lockwood GB: Octacosanol in human health. Nutrition. 2003 Feb;19(2):192-5. [Article]
Human Metabolome Database
HMDB0034380
KEGG Compound
C08387
PubChem Compound
68406
PubChem Substance
347827945
ChemSpider
61689
RxNav
12166
ChEBI
28243
ChEMBL
CHEMBL1951714
ZINC
ZINC000008221075
PDBe Ligand
O8N
Wikipedia
1-Octacosanol
PDB Entries
5tvi

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
Not AvailableCompletedTreatmentHigh Cholesterol1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral
TabletOral
CapsuleOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.25e-05 mg/mLALOGPS
logP10.25ALOGPS
logP11.47Chemaxon
logS-7.5ALOGPS
pKa (Strongest Acidic)16.84Chemaxon
pKa (Strongest Basic)-2Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area20.23 Å2Chemaxon
Rotatable Bond Count26Chemaxon
Refractivity132.56 m3·mol-1Chemaxon
Polarizability60.17 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Mass Spectrum (Electron Ionization)MSsplash10-0a5c-9200000000-d4468fe1021d0799c6d5
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-01ox-0019600000-845b2a7dd4bb712ef7b5
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-3459200000-7d4ea0ce8ec306880a4f
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052f-5964000000-dfc15a4fc90a524158ff
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-0003900000-79a6dbdbe8e2769811a8
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-1009800000-b1f2b2bd96e29dc484ea
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-002f-8559000000-718f819a53882d7149b4
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable

Drug created at December 03, 2015 16:51 / Updated at June 12, 2020 16:53